LATS1 and renal cell carcinoma: Treatment of RCC cells with the DNA methylation inhibitor 5‐aza‐2′‐deoxycytidine can demethylate LATS1, downregulate YAP expression, promote cell apoptosis, arrest the cell cycle, and inhibit cell proliferation.62